O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$108M
2
+$75.4M
3
+$71.1M
4
LLY icon
Eli Lilly
LLY
+$70.2M
5
UNH icon
UnitedHealth
UNH
+$67.9M

Top Sells

1
+$205M
2
+$149M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$59.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$48.6M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$487M 5.14%
7,624,900
-770,100
2
$448M 4.73%
5,737,100
-218,500
3
$431M 4.55%
2,876,000
-45,000
4
$423M 4.46%
22,479,700
-1,951,200
5
$422M 4.46%
7,395,700
-52,800
6
$422M 4.45%
1,572,715
+148,000
7
$397M 4.19%
1,526,300
+83,800
8
$378M 3.99%
3,774,077
+108,627
9
$277M 2.93%
3,019,200
-402,200
10
$260M 2.75%
1,870,600
-404,500
11
$217M 2.29%
6,776,100
+112,000
12
$203M 2.14%
1,435,000
+55,000
13
$200M 2.11%
2,755,078
-77,900
14
$192M 2.03%
533,000
+50,000
15
$183M 1.93%
2,541,300
+928,300
16
$177M 1.86%
1,903,300
+557,100
17
$166M 1.76%
2,491,200
+340,200
18
$166M 1.76%
2,421,000
+239,000
19
$149M 1.57%
1,869,400
+1,196,400
20
$146M 1.54%
925,200
+23,644
21
$144M 1.52%
2,696,000
+250,000
22
$144M 1.52%
1,120,000
23
$139M 1.47%
3,495,000
+169,000
24
$139M 1.46%
8,345,110
+99,999
25
$130M 1.37%
1,909,000
+76,000
1
2 3 4 5